Systemic Delivery of Bone Marrow-Derived Mesenchymal Stromal Cells Diminishes Neuropathology in a Mouse Model of Krabbe's Disease
Authors:
- Catarina Oliveira MirandaCMCatarina Oliveira Miranda
- Carla Andreia TeixeiraCTCarla Andreia Teixeira
- Márcia Almeida LizMLMárcia Almeida Liz
- Vera Filipe SousaVSVera Filipe Sousa
- Filipa FranquinhoFFFilipa Franquinho
- Giancarlo ForteGFGiancarlo Forte
- Paolo Di NardoPNPaolo Di Nardo
- Perpétua Pinto-Do-ÓPPPerpétua Pinto-Do-Ó
- Mónica Mendes SousaMónica Mendes Sousa
Open Access
- 25 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 29 (11) , 1738-1751
Abstract
In Krabbe's disease, a demyelinating disorder, add-on strategies targeting the peripheral nervous system (PNS) are needed, as it is not corrected by bone-marrow (BM) transplantation. To circumvent this limitation of BM transplantation, we assessed whether i.v. delivery of immortalized EGFP+ BM-derived murine mesenchymal stromal cells (BM-MSCTERT-EGFP) targets the PNS of a Krabbe's disease model, the Twitcher mouse. In vitro, BM-MSCTERT-EGFP retained the phenotype of primary BM-MSC and did not originate tumors upon transplantation in nude mice. In vivo, undifferentiated EGFP+ cells grafted the Twitcher sciatic nerve where an increase in Schwann cell precursors and axonal number was detected. The same effect was observed on BM-MSCTERT-EGFP i.v. delivery following sciatic nerve crush, a model of axonal regeneration. Reiterating the in vivo findings, in a coculture system, BM-MSCTERT-EGFP induced the proliferation of Twitcher-derived Schwann cells and the neurite outgrowth of both Twitcher-derived neurons and wild-type neurons grown in the presence of psychosine, the toxic substrate that accumulates in Krabbe's disease. In vitro, this neuritogenic effect was blocked by K252a, an antagonist of Trk receptors, and by antibody blockage of brain derived neurotrophic factor, a neurotrophin secreted by BM-MSCTERT-EGFP and induced in neighboring Schwann cells. In vivo, BM-MSCTERT-EGFP surmounted the effect of K252a, indicating their ability to act through a neurotrophin-independent mechanism. In summary, i.v. delivery of BM-MSCTERT-EGFP exerts a multilevel effect targeting neurons and Schwann cells, coordinately diminishing neuropathology. Therefore, to specifically target the PNS, MSC should be considered an add-on option to BM transplantation in Krabbe's disease and in other disorders where peripheral axonal loss occurs.Keywords
Funding Information
- European Leukodystrophy Association (PTDC/SAU-OSM-68473/2006)
- Fundação para a Ciência e Tecnologia, Portugal
- Programa Ciência, funded by POPH-QREN and MCTES
- Fundação para a Ciência e Tecnologia (SFRH/BD/29768/2006, BPD/34811/2007)
- Biomaterials Center and International Center for Materials Nanoarchitectonics
- National Institute for Materials Science (NIMS), Tsukuba, Japan
This publication has 59 references indexed in Scilit:
- Mesenchymal Lineage Stem Cells Have Pronounced Anti-Inflammatory Effects in the Twitcher Mouse Model of Krabbe's DiseaseStem Cells, 2010
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Interfacing Sca‐1pos Mesenchymal Stem Cells with Biocompatible Scaffolds with Different Chemical Composition and GeometryBioMed Research International, 2009
- Peripheral nerve regeneration by the in vitro differentiated-human bone marrow stromal cells with Schwann cell propertyBiochemical and Biophysical Research Communications, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells, 2007
- Transdifferentiated Mesenchymal Stem Cells as Alternative Therapy in Supporting Nerve Regeneration and MyelinationCellular and Molecular Neurobiology, 2006
- Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growthOncogene, 2005
- Intravenous Administration of Marrow Stromal Cells (MSCs) Increases the Expression of Growth Factors in Rat Brain after Traumatic Brain InjuryJournal of Neurotrauma, 2004
- Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cellsNature Biotechnology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001